Post‑COVID Resurgence of Mycoplasma pneumoniae in French Children: Hospital Burden, Risk Factors for ICU Admission, and Clinical Implications
Highlights
• The ORIGAMI multicentre cohort (37 French paediatric hospitals) identified 969 children hospitalised with Mycoplasma pneumoniae during the 2023–24 resurgence; PCR confirmed infection in 97%.
• Pneumonia predominated among respiratory presentations (87% of those with respiratory involvement); cutaneous manifestations occurred in 14%, with erythema multiforme present in 42% of these.
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.